Literature DB >> 23454129

Serum amyloid A stimulates macrophage foam cell formation via lectin-like oxidized low-density lipoprotein receptor 1 upregulation.

Ha Young Lee1, Sang Doo Kim, Suk-Hwan Baek, Joon Hyuk Choi, Kyung-Hyun Cho, Brian A Zabel, Yoe-Sik Bae.   

Abstract

Elevated levels of serum amyloid A (SAA) is a risk factor for cardiovascular diseases, however, the role of SAA in the pathophysiology of atherosclerosis remains unclear. Here we show that SAA induced macrophage foam cell formation. SAA-stimulated foam cell formation was mediated by c-jun N-terminal kinase (JNK) signaling. Moreover, both SAA and SAA-conjugated high density lipoprotein stimulated the expression of the important scavenger receptor lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) via nuclear factor-κB (NF-κB). A LOX1 antagonist carrageenan significantly blocked SAA-induced foam cell formation, indicating that SAA promotes foam cell formation via LOX1 expression. Our findings therefore suggest that SAA stimulates foam cell formation via LOX1 induction, and thus likely contributes to atherogenesis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23454129      PMCID: PMC3670953          DOI: 10.1016/j.bbrc.2013.02.077

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

1.  ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity.

Authors:  Shilpi Nandi; Loretta Ma; Maxime Denis; Joel Karwatsky; Zhiqiang Li; Xian-Cheng Jiang; Xiaohui Zha
Journal:  J Lipid Res       Date:  2008-10-21       Impact factor: 5.922

Review 2.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

3.  LOX-1 transcription.

Authors:  Paul L Hermonat; Hongqing Zhu; Maohua Cao; Jawahar L Mehta
Journal:  Cardiovasc Drugs Ther       Date:  2011-10       Impact factor: 3.727

4.  A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil.

Authors:  C J Furlaneto; A Campa
Journal:  Biochem Biophys Res Commun       Date:  2000-02-16       Impact factor: 3.575

Review 5.  Biology and action of colony--stimulating factor-1.

Authors:  E R Stanley; K L Berg; D B Einstein; P S Lee; F J Pixley; Y Wang; Y G Yeung
Journal:  Mol Reprod Dev       Date:  1997-01       Impact factor: 2.609

Review 6.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

7.  A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation.

Authors:  Jin-Gu Lee; Eun-Jung Lim; Dae-Weon Park; Sun-Hye Lee; Jae-Ryong Kim; Suk-Hwan Baek
Journal:  Cell Signal       Date:  2008-09-11       Impact factor: 4.315

Review 8.  Serum amyloid A (SAA): an acute phase protein and apolipoprotein.

Authors:  E Malle; A Steinmetz; J G Raynes
Journal:  Atherosclerosis       Date:  1993-09       Impact factor: 5.162

9.  Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes.

Authors:  Tomohiro Koga; Takafumi Torigoshi; Satoru Motokawa; Taichiro Miyashita; Yumi Maeda; Minoru Nakamura; Atsumasa Komori; Yoshihiro Aiba; Takashi Uemura; Hiroshi Yatsuhashi; Hiromi Ishibashi; Katsumi Eguchi; Kiyoshi Migita
Journal:  FEBS Lett       Date:  2008-02-01       Impact factor: 4.124

10.  Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.

Authors:  Mauro Perretti; Roderick J Flower; Neil Dufton; Robert Hannon; Vincenzo Brancaleone; Jesmond Dalli; Hetal B Patel; Mohini Gray; Fulvio D'Acquisto; Julia C Buckingham
Journal:  J Immunol       Date:  2010-01-27       Impact factor: 5.422

View more
  18 in total

1.  A brief elevation of serum amyloid A is sufficient to increase atherosclerosis.

Authors:  Joel C Thompson; Colton Jayne; Jennifer Thompson; Patricia G Wilson; Meghan H Yoder; Nancy Webb; Lisa R Tannock
Journal:  J Lipid Res       Date:  2014-11-26       Impact factor: 5.922

2.  Serum amyloid A regulates monopoiesis in hyperlipidemic Ldlr(-/-) mice.

Authors:  Paulette A Krishack; Timothy J Sontag; Godfrey S Getz; Catherine A Reardon
Journal:  FEBS Lett       Date:  2016-07-08       Impact factor: 4.124

3.  Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages.

Authors:  Qian Yan; Lei Sun; Ziyan Zhu; Lili Wang; Shuqin Li; Richard D Ye
Journal:  Cell Signal       Date:  2014-04-01       Impact factor: 4.315

4.  Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of serum amyloid A as a potential marker.

Authors:  Antonio J Lepedda; Gabriele Nieddu; Elisabetta Zinellu; Pierina De Muro; Franco Piredda; Anna Guarino; Rita Spirito; Franco Carta; Francesco Turrini; Marilena Formato
Journal:  Oxid Med Cell Longev       Date:  2013-12-24       Impact factor: 6.543

5.  Adipose tissue-derived human serum amyloid a does not affect atherosclerotic lesion area in hSAA1+/-/ApoE-/- mice.

Authors:  Sofie Ahlin; Maja Olsson; Anna S Wilhelmson; Kristina Skålén; Jan Borén; Lena M S Carlsson; Per-Arne Svensson; Kajsa Sjöholm
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 6.  Non-tumor necrosis factor-based biologic therapies for rheumatoid arthritis: present, future, and insights into pathogenesis.

Authors:  Filipe Seguro Paula; José Delgado Alves
Journal:  Biologics       Date:  2013-12-09

Review 7.  Particle-induced pulmonary acute phase response may be the causal link between particle inhalation and cardiovascular disease.

Authors:  Anne T Saber; Nicklas R Jacobsen; Petra Jackson; Sarah Søs Poulsen; Zdenka O Kyjovska; Sabina Halappanavar; Carole L Yauk; Håkan Wallin; Ulla Vogel
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-06-12

8.  CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice.

Authors:  Xiao-Qing Wang; Hui-Qing Wan; Xian-Jing Wei; Ying Zhang; Peng Qu
Journal:  Mol Med Rep       Date:  2016-05-10       Impact factor: 2.952

9.  Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice.

Authors:  Paulette A Krishack; Clarissa V Bhanvadia; John Lukens; Timothy J Sontag; Maria C De Beer; Godfrey S Getz; Catherine A Reardon
Journal:  J Am Heart Assoc       Date:  2015-07-17       Impact factor: 5.501

10.  Multi-walled carbon nanotube-physicochemical properties predict the systemic acute phase response following pulmonary exposure in mice.

Authors:  Sarah S Poulsen; Kristina B Knudsen; Petra Jackson; Ingrid E K Weydahl; Anne T Saber; Håkan Wallin; Ulla Vogel
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.